Reduced serum ghrelin in a putative postmenopausal polycystic ovary syndrome phenotype

Fertility and Sterility

Volumn 92, Issue 5, 2009, Pages 1753-1754

  Krentz, Andrew J ^a   Barrett Connor, Elizabeth ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN;

AGED; ARTICLE; COHORT ANALYSIS; COMMUNITY LIVING; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FREEZING; HUMAN; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PHENOTYPE; POSTMENOPAUSE; PRIORITY JOURNAL; THAWING;

AGED; AGED, 80 AND OVER; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DOWN-REGULATION; FEMALE; GHRELIN; HUMANS; PHENOTYPE; POLYCYSTIC OVARY SYNDROME; POSTMENOPAUSE; RESIDENCE CHARACTERISTICS;

EID: 70350570535     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.05.039     Document Type: Article

References (10)

1. Barreiro M.L., and Tena-Sempere M. Ghrelin and reproduction: a novel signal linking energy status and fertility?. Mol Cell Endocrinol 226 (2004) 1-9
2. Garcia M.C., Lopez M., Alvarez C.V., Casanueva F., Tena-Sempere M., and Dieguez C. Role of ghrelin in reproduction. Reproduction 133 (2007) 531-540
3. Schofl C., Horn R., Schill T., Schlosser H.W., Muller M.J., and Brabant G. Circulating ghrelin levels in patients with polycystic ovary syndrome. J Clin Endocrinol Metab 87 (2002) 4607-4610
4. Glintborg D., Andersen M., Hagen C., Frystyk J., Hulstrom V., Flyvbjerg A., et al. Evaluation of metabolic risk markers in polycystic ovary syndrome (PCOS). Adiponectin, ghrelin, leptin and body composition in hirsute PCOS patients and controls. Eur J Endocrinol 155 (2006) 337-345
5. Mitkov M., Pehlivanov B., and Orbetzova M. Serum ghrelin level in women with polycystic ovary syndrome and its relationship with endocrine and metabolic parameters. Gynecol Endocrinol 24 (2008) 625-630
6. Pagotto U., Gambineri A., Vicennati V., Heiman M.L., Tschop M., and Pasquali R. Plasma ghrelin, obesity, and the polycystic ovary syndrome: correlation with insulin resistance and androgen levels. J Clin Endocrinol Metab 87 (2002) 5625-5629
7. Krentz A.J., von Muhlen D., and Barrett-Connor E. Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease. Menopause 14 (2007) 284-292
8. Azziz R., Carmina E., Dewailly D., Diamanti-Kandarakis E., Escobar-Morreale H.F., Futterweit W., et al. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertil Steril 91 (2009) 456-488
9. Groschl M., Wagner R., Dotsch J., Rascher W., and Rauh M. Preanalytical influences on the measurement of ghrelin. Clin Chem 48 (2002) 1114-1116
10. Chu M.C., Cosper P., Nakhuda G.S., and Lobo R.A. A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome. Fertil Steril 86 (2006) 1669-1675